As you prepare your abstract for the 2018 AMP Annual Meeting & Expo, consider that our theme this year is, "Precision Medicine Starts Here." Your exciting new work presented in abstract form will round out our relevant and comprehensive program. The Program Committee recognizes that abstracts contain cutting-edge work in our rapidly evolving field. The work you present will lead to new methods and diagnostic markers to achieve outstanding patient care. Some of the most enthusiastic discussion and productive collaborations begin at the poster sessions and continue throughout the meeting and beyond. We look forward to your submissions and to seeing you in November in San Antonio!
Abstract Submission Opens:
March 31, 2018
Abstract Submission Closes:
11:59 PM ET, Thursday May 31, 2018
11:59 PM ET, Wednesday August 1, 2018
All participants at the AMP 2018 Annual Meeting & Expo are invited to submit abstracts of original studies related to molecular pathology and diagnostics.
QUICK LINKS / RESOURCES
Only AMP Regular Members are eligible to submit abstracts. Associate Members (Trainees) and non-members must have a Regular Member sponsor their abstract. The Regular Member does not need to be an author on the abstract. If you are not a Regular Member of AMP, join now to submit your abstract today. You may submit an abstract and apply to join AMP on the same day, up to and through the submission deadline. However, we encourage you to join AMP in advance of the deadline!
*Abstract submissions in the "Other (Education, etc.)" topic category may include descriptions of novel educational approaches, innovative programs, pioneering technologies, etc. As with other abstract submissions, these abstract submissions must demonstrate the scientific method, i.e., describe the methodology and data collection, identify how to measure, analyze, and report outcomes, and provide conclusions. All submitted abstracts will be reviewed with the same criteria (see below).
Submission: May 31, 2018 at 11:59 pm ET. NO EXCEPTIONS. The final abstract submission step is not complete until you have clicked the "Save and Finalize" button. The Corresponding Author will receive a confirmation email, but only after the abstract has been successfully finalized and submitted. Abstracts that are in process but not finalized after the deadline will not be considered for acceptance and/or awards.
Notification: The Corresponding Author will be notified by email no later than mid-July. Accepted abstracts will be published in the November 2018 issue of The Journal of Molecular Diagnostics (JMD) (see "Eligibility for Publication" section). Abstracts that are not eligible for publication in JMD, i.e., have been submitted to another publication or to another meeting that occurs before November 2018, will be rejected. Abstracts may be withdrawn until 11:59 pm ET on August 1, 2018.
Embargo: The research presented as posters at the AMP Annual Meeting & Expo from the abstracts published in the November issue of JMD is embargoed until the first day of poster presentations at the Annual Meeting.
Poster Presentation: First authors of accepted abstracts are expected to register as an attendee and present posters at the Annual Meeting & Expo summarizing their studies. All authors of abstracts must adhere to the AMP Scientific Integrity Policy.
Note: Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.
Abstracts must be submitted properly. The online system is a database, with data fields (title, author 1, author 2, author 3, etc) that are used to generate the published abstracts. Therefore, pay careful attention to the submission instructions and to the submission process, including spelling, capitalization, author names, etc.
All abstracts must include the required headers listed below; each header must be included in your text:
Conclusions: the conclusions and/or implications of the results
Abstract Content: 2800 characters (with spaces and including section headers)
You may include formatting (e.g. italicizing genes), Greek letters and special symbols, e.g. °C (degree sign), superscripts, etc. Data must be reported in narrative format in the abstract submission; tables may be included in your poster.
Only AMP Regular Members are eligible to submit abstracts. Associate Members and non-members must have a Regular Member sponsor their abstract. If you are not a Regular member of AMP, join now to submit your abstract today. You may submit an abstract and apply to join AMP on the same day, up to and through the submission deadline. However, we encourage you to join AMP in advance of the deadline!
Your abstract must be eligible for publication in The Journal of Molecular Diagnostics (JMD) will be rated using four criteria:
Abstracts that have been submitted to other meetings that occur earlier in the year should be revised, e.g., with additional data, before submitting to the AMP Annual Meeting & Expo.
Your abstract will be rated using four criteria:
Summary: Grounds for abstract rejection are:
The five most common reasons for rejection are:
Additional reasons for administrative abstract rejection without review include:
If you receive a character count error after submitting your abstract, please note the following:
This count error happens when there are hidden characters in the abstract’s text, which is not unusual if the text has been copied from somewhere else. If the text is written from scratch in the submission box, the character count error is not likely. We suggest entering text manually rather than copying and pasting the text from other documents. Alternatively, you could also try copying the text of the abstract to Notepad first, then from Notepad to the submission form. This usually removes hidden and special characters.
Please visit the links below to read other information about the abstract submission process:
Upon entering the abstract submission system, do not use your Internet browser’s back button. Instead, click on the “Prev” button next to the “Save and Next” button at the bottom right of each form page.
The Corresponding (Submitting) Author is the individual who submits the abstract and is the contact person for all correspondence from AMP. The Corresponding Author does not need to be the senior author. The Corresponding Author has the following responsibilities and will:
Be responsible for compliance with the AMP Scientific Integrity Policy.
The First Author is also considered the Presenting Author (who may be the Corresponding Author), has the following responsibilities, and will:
Ensure that the abstract poster conforms to the Rules for Poster Display at the Annual Meeting & Expo (i.e., poster display size, format, and schedule).
Please note that:
The Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP) are the co-owners of JMD and own the copyright for all manuscripts and abstracts published in the journal. The Corresponding (Submitting) author must verify at the time of abstract submission that, if the abstract is accepted, all authors agree to (1) publication of the abstract in JMD, and (2) transfer copyright ownership to AMP and ASIP. For US government employees, the above assignment applies only to the extent allowed by law. For more information on publication in JMD, please see this link.
*This will also be a checkbox on the submission form.